Sean Maduck - 08 Jan 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck
Issuer symbol
CORT
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 16:25:58 UTC
Previous filing
03 Dec 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maduck Sean Officer C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck 13 Feb 2026 0001698310

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Gift $0 -20,570 -34% $0.000000 39,147 08 Jan 2026 See Footnote F1
transaction CORT Common Stock Other $0 +20,570 $0.000000 20,570 08 Jan 2026 See Footnote F2
transaction CORT Common Stock Gift $0 -34,000 -87% $0.000000 5,147 08 Jan 2026 See Footnote F1
transaction CORT Common Stock Other $0 +34,000 $0.000000 34,000 08 Jan 2026 See Footnote F3
holding CORT Common Stock 8,179 08 Jan 2026 Direct F4
holding CORT Common Stock 40,000 08 Jan 2026 See Footnote F5
holding CORT Common Stock 10,000 08 Jan 2026 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
F2 Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.
F3 Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
F4 Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 205 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F5 Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
F6 Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Remarks:

President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.